Proteus Digital Health Announces FDA Clearance of Ingestible Sensor

August 30, 2012 | Permalink

Proteus Digital Health, Inc. announced today that the U.S. Food and Drug Administration (FDA) has cleared its ingestible sensor for marketing as a medical device.

Read more

Posted in Type I Type II Glucose & Insulin



  • Recent Posts